Skip to main content
OpenTrials

Clinical trial condition

Nonalcoholic Fatty Liver Disease (NAFLD)

Explore clinical trials studying Nonalcoholic Fatty Liver Disease (NAFLD). Study availability and eligibility vary by location and protocol.

16 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Nonalcoholic Fatty Liver Disease (NAFLD) trial results

Recruiting

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT07093346

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +11 more
Locations
  • Sir Peter Mansfield Imaging Centre, University of Nottingham Nottingham, United Kingdom
  • Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust Nottingham, United Kingdom
  • University of Nottingham Nottingham, United Kingdom
View Trial Details
Completed

A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

NCT06024408

Conditions
Digestive System Diseases, Fatty Liver, Genetic Risk Factor, +4 more
Locations
  • Chungbuk National University Hospital Cheongju-si, Chungcheong Buk-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital Seoul, South Korea
View Trial Details
Completed

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +9 more
Locations
  • North Alabama Health Research, LLC Madison, Alabama, United States
  • Local Institution - 0005 Chandler, Arizona, United States
  • Local Institution - 0088 Phoenix, Arizona, United States
  • Local Institution - 0006 Phoenix, Arizona, United States
View all 91 locations
View Trial Details
Completed

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

NCT03486899

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +8 more
Locations
  • Local Institution - 0087 Madison, Alabama, United States
  • Local Institution - 0005 Chandler, Arizona, United States
  • Local Institution - 0088 Phoenix, Arizona, United States
  • Local Institution - 0001 Phoenix, Arizona, United States
View all 89 locations
View Trial Details

Related conditions